BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18323740)

  • 1. A 20-hydroxyeicosatetraenoic acid agonist, N-[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine, opposes the fall in blood pressure and vascular reactivity in endotoxin-treated rats.
    Tunctan B; Korkmaz B; Buharalioglu CK; Firat SS; Anjaiah S; Falck J; Roman RJ; Malik KU
    Shock; 2008 Sep; 30(3):329-35. PubMed ID: 18323740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of iNOS/sGC/PKG pathway, COX-2, CYP4A1, and gp91(phox) to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against vasodilation, hypotension, tachycardia, and inflammation in a rat model of septic shock.
    Tunctan B; Korkmaz B; Sari AN; Kacan M; Unsal D; Serin MS; Buharalioglu CK; Sahan-Firat S; Cuez T; Schunck WH; Manthati VL; Falck JR; Malik KU
    Nitric Oxide; 2013 Sep; 33():18-41. PubMed ID: 23684565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A synthetic analogue of 20-HETE, 5,14-HEDGE, reverses endotoxin-induced hypotension via increased 20-HETE levels associated with decreased iNOS protein expression and vasodilator prostanoid production in rats.
    Cuez T; Korkmaz B; Buharalioglu CK; Sahan-Firat S; Falck J; Malik KU; Tunctan B
    Basic Clin Pharmacol Toxicol; 2010 May; 106(5):378-88. PubMed ID: 20002062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5,14-HEDGE, a 20-HETE mimetic, reverses hypotension and improves survival in a rodent model of septic shock: contribution of soluble epoxide hydrolase, CYP2C23, MEK1/ERK1/2/IKKβ/IκB-α/NF-κB pathway, and proinflammatory cytokine formation.
    Tunctan B; Korkmaz B; Sari AN; Kacan M; Unsal D; Serin MS; Buharalioglu CK; Sahan-Firat S; Cuez T; Schunck WH; Falck JR; Malik KU
    Prostaglandins Other Lipid Mediat; 2013; 102-103():31-41. PubMed ID: 23454652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of PPARα/β/γ, AP-1, importin-α3, and RXRα to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against hypotension, tachycardia, and inflammation in a rat model of septic shock.
    Senol SP; Temiz M; Guden DS; Cecen P; Sari AN; Sahan-Firat S; Falck JR; Dakarapu R; Malik KU; Tunctan B
    Inflamm Res; 2016 May; 65(5):367-87. PubMed ID: 26875149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 5,14-HEDGE, a 20-HETE mimetic, on lipopolysaccharide-induced changes in MyD88/TAK1/IKKβ/IκB-α/NF-κB pathway and circulating miR-150, miR-223, and miR-297 levels in a rat model of septic shock.
    Sari AN; Korkmaz B; Serin MS; Kacan M; Unsal D; Buharalioglu CK; Sahan Firat S; Manthati VL; Falck JR; Malik KU; Tunctan B
    Inflamm Res; 2014 Sep; 63(9):741-56. PubMed ID: 24915805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of GPR75 Signaling Pathway Contributes to the Effect of a 20-HETE Mimetic, 5,14-HEDGE, to Prevent Hypotensive and Tachycardic Responses to Lipopolysaccharide in a Rat Model of Septic Shock.
    Tunctan B; Senol SP; Temiz-Resitoglu M; Yilmaz DE; Guden DS; Bahceli O; Horat MF; Sahan-Firat S; Sari AN; Falck JR; Anugu RR; Malik KU
    J Cardiovasc Pharmacol; 2022 Aug; 80(2):276-293. PubMed ID: 35323151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of vasoactive eicosanoids and nitric oxide production to the effect of selective cyclooxygenase-2 inhibitor, NS-398, on endotoxin-induced hypotension in rats.
    Tunctan B; Korkmaz B; Cuez T; Kemal Buharalioglu C; Sahan-Firat S; Falck J; Malik KU
    Basic Clin Pharmacol Toxicol; 2010 Nov; 107(5):877-82. PubMed ID: 22545970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a 20-HETE antagonist and agonists on cerebral vascular tone.
    Yu M; Cambj-Sapunar L; Kehl F; Maier KG; Takeuchi K; Miyata N; Ishimoto T; Reddy LM; Falck JR; Gebremedhin D; Harder DR; Roman RJ
    Eur J Pharmacol; 2004 Feb; 486(3):297-306. PubMed ID: 14985052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel treatment strategy for sepsis and septic shock based on the interactions between prostanoids, nitric oxide, and 20-hydroxyeicosatetraenoic acid.
    Tunctan B; Korkmaz B; Sari AN; Kacan M; Unsal D; Serin MS; Buharalioglu CK; Sahan-Firat S; Schunck WH; Falck JR; Malik KU
    Antiinflamm Antiallergy Agents Med Chem; 2012; 11(2):121-50. PubMed ID: 23013331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Piroxicam reverses endotoxin-induced hypotension in rats: contribution of vasoactive eicosanoids and nitric oxide.
    Buharalioglu CK; Korkmaz B; Cuez T; Sahan-Firat S; Sari AN; Malik KU; Tunctan B
    Basic Clin Pharmacol Toxicol; 2011 Sep; 109(3):186-94. PubMed ID: 21463481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of 20-HETE analogues in experimental renal ischemia reperfusion injury.
    Regner KR; Zuk A; Van Why SK; Shames BD; Ryan RP; Falck JR; Manthati VL; McMullen ME; Ledbetter SR; Roman RJ
    Kidney Int; 2009 Mar; 75(5):511-7. PubMed ID: 19052533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue protection and endothelial cell signaling by 20-HETE analogs in intact ex vivo lung slices.
    Jacobs ER; Bodiga S; Ali I; Falck AM; Falck JR; Medhora M; Dhanasekaran A
    Exp Cell Res; 2012 Oct; 318(16):2143-52. PubMed ID: 22687879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of MEK1/ERK1/2/iNOS/sGC/PKG pathway associated with peroxynitrite formation contributes to hypotension and vascular hyporeactivity in endotoxemic rats.
    Korkmaz B; Buharalioglu K; Sahan-Firat S; Cuez T; Tuncay Demiryurek A; Tunctan B
    Nitric Oxide; 2011 Apr; 24(3):160-72. PubMed ID: 21354320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock.
    Wu CC; Chen SJ; Szabó C; Thiemermann C; Vane JR
    Br J Pharmacol; 1995 Apr; 114(8):1666-72. PubMed ID: 7541282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of extracellular signal-regulated kinase (ERK1/2) activity reverses endotoxin-induced hypotension via decreased nitric oxide production in rats.
    Tunctan B; Korkmaz B; Dogruer ZN; Tamer L; Atik U; Buharalioglu CK
    Pharmacol Res; 2007 Jul; 56(1):56-64. PubMed ID: 17524662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock.
    Szabó C; Mitchell JA; Thiemermann C; Vane JR
    Br J Pharmacol; 1993 Mar; 108(3):786-92. PubMed ID: 7682137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetramethylpyradizine prevents inducible NO synthase expression and improves survival in rodent models of endotoxic shock.
    Wu CC; Liao MH; Chen SJ; Yen MH
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Oct; 360(4):435-44. PubMed ID: 10551281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of early versus delayed use of norepinephrine in resuscitated endotoxic shock.
    Sennoun N; Montemont C; Gibot S; Lacolley P; Levy B
    Crit Care Med; 2007 Jul; 35(7):1736-40. PubMed ID: 17522580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of 20-hydroxyeicosatetraenoic acid reduce renal vasoconstrictor responsiveness.
    Quilley J; Qiu Y; Hirt J
    J Pharmacol Exp Ther; 2003 Oct; 307(1):223-9. PubMed ID: 12954811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.